Companies ›Healthcare ›OUEE.SI

OUEE.SI — SGX Healthcare Facilities & Services

OUE Healthcare Ltd

$0,03

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

—

ROE

—

Net margin

—

Debt / equity

—

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

OUE Healthcare Ltd operates in the healthcare facilities and services industry, providing pharmaceutical and healthcare services.

Business. OUE Healthcare Ltd (OUEE.SI) is a healthcare company engaged in the healthcare facilities and services industry, with activities including pharmaceuticals. The firm operates on a service-revenue model and is headquartered in Singapore. It is primarily listed on the Singapore Exchange (SGX). Specific details regarding operating segments and geographic revenue mix are not available.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityPharmaceuticals

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability

—

not yet wired

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning OUEE.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to OUEE.SI. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

OUE Healthcare Ltd (OUEE.SI) is a healthcare company engaged in the healthcare facilities and services industry, with activities including pharmaceuticals. The firm operates on a service-revenue model and is headquartered in Singapore. It is primarily listed on the Singapore Exchange (SGX). Specific details regarding operating segments and geographic revenue mix are not available.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityPharmaceuticals

AI synthesis

GENERATED

OUE Healthcare Ltd has a basic and diluted share count of 4.44 billion shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.

The company reported a last actual EPS of 0.04 SGD and a last actual revenue of 31.32 million SGD, suggesting a modest revenue base and earnings performance. These figures are below the typical thresholds for high-growth healthcare firms, indicating a need for further analysis of profitability and returns.

OUE Healthcare Ltd's revenue is not segmented by geographic region or business line in the available data, making it difficult to assess geographic or product concentration risk. The lack of segmental data limits the ability to evaluate exposure to specific markets or services.

The company's growth trajectory is not clearly defined in the available data, with no forward-looking revenue or earnings guidance provided. The absence of a detailed outlook makes it challenging to assess the company's future performance and strategic direction.

The risk assessment indicates a low dilution risk, but the liquidity risk remains unassessed. The company has not disclosed any recent events, filings, or transcripts that would provide additional insight into its operational or financial status.

Key takeaways

OUE Healthcare Ltd has a basic and diluted share count of 4.44 billion, with no immediate dilution pressure.
The company reported a last actual EPS of 0.04 SGD and a last actual revenue of 31.32 million SGD.
Revenue and earnings figures are below typical thresholds for high-growth healthcare firms.
The company's growth trajectory is not clearly defined, with no forward-looking guidance provided.
The liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Annual

ANNUALFiled 2014-04-21

FY 2014 · Full-year highlights

Revenue SGD 152.4M, +1,4% YoY; Operating income −15,5% YoY.

RevenueSGD 152.4M+1,4 % YoY

Operating incomeSGD 62.6M−15,5 % YoY

Net income-SGD 16.9M−181,1 % YoY

Free cash flowSGD 9.9M−63,7 % YoY

EPS—

Operating cash flowSGD 56.4M−7,1 % YoY

Financials

Income statement

RevenueSGD 152.4M

Gross profitSGD 114.4M

Operating incomeSGD 62.6M

Net income-SGD 16.9M

Margins

Gross margin75.1%

Operating margin41.1%

Net margin-11.1%

FCF margin6.5%

Balance sheet

Total assetsSGD 1.32B

Total liabilitiesSGD 1.07B

Total equitySGD 247.1M

Cash & equivalentsSGD 18.8M

Long-term debtSGD 541.1M

Cash flow

Operating cash flowSGD 56.4M

CapEx-SGD 1.6M

Free cash flowSGD 9.9M

SBC—

P&L flow · revenue → net income

Highlights

▍Revenue SGD 152.4M, +1,4% YoY
▍Operating income −15,5% YoY
▍Net income −181,1% YoY
▍Free cash flow −63,7% YoY
▍Net margin -11.1%

Valuation FY

Market price

$0,03

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

—

Net cashⓘ

—

Current ratioⓘ

—

Debt / equityⓘ

—

ROAⓘ

—

ROEⓘ

—

Cash conversionⓘ

—

CapEx / revenueⓘ

—

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskUnknown

Benchmarks vs cohort

No cohort benchmark data available for this issuer yet.

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic

Source documents

OUE Healthcare Ltd Market data — financials · 2026-05-28
OUE Healthcare Ltd Market data — analyst estimates · 2026-05-28

Ownership & reference

Leadership

Kum Meng YetChief Executive Officer, Executive Director

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

OUEE.SICanonical

SGX · USD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskUnknown

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

2014-04-21 17:09 UTCEARNINGSAnnual results — FY 2014 Revenue SGD 152.4M · Net SGD -16.9M

The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation FY

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Leadership

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread